Pentraxin-3作为脓毒症死亡预测标志物的更新系统评价与荟萃分析
该系统评价与荟萃分析检索PubMed、EMBASE和Cochrane图书馆截至2021年1月的文献,纳入17项队列和病例对照研究、共3658例脓毒症患者。结果显示,死亡者PTX3水平显著高于存活者(SMD -1.06,95%CI -1.43至-0.69,P<0.001),PTX3升高与死亡显著相关(HR 2.09,95%CI 1.55至2.81,P<0.001),对死亡预测能力良好(AUC 0.73,95%CI 0.70至0.77,P<0.001)。多因素回归分析显示,非死亡者与存活者PTX3比较及PTX3与死亡关联的结果与样本量相关,但与男性比例无关;AUC与样本量和男性比例均相关。
要点
- 在3658例脓毒症患者中,死亡者PTX3水平显著高于存活者,SMD为-1.06(95%CI -1.43至-0.69,P<0.001)。
- PTX3水平升高与脓毒症患者死亡显著相关,HR为2.09(95%CI 1.55至2.81,P<0.001)。
- PTX3对脓毒症患者死亡具有良好预测能力,AUC为0.73(95%CI 0.70至0.77,P<0.001)。
- 比较死亡者与存活者PTX3水平及PTX3与死亡关联的结果与样本量相关,但与男性比例无关。
- PTX3预测死亡的AUC与样本量和男性比例均相关。
适用人群与场景
- 脓毒症患者(17项队列和病例对照研究,共3658例)
研究设计与关键结果
- 研究类型:系统评价与荟萃分析,纳入17项队列和病例对照研究,共3658例脓毒症患者。
- 死亡者PTX3水平显著高于存活者(SMD -1.06,95%CI -1.43至-0.69,P<0.001)。
- PTX3水平升高与死亡显著相关(HR 2.09,95%CI 1.55至2.81,P<0.001)。
- PTX3对死亡预测能力良好(AUC 0.73,95%CI 0.70至0.77,P<0.001)。
- 多因素回归分析显示,比较死亡者与存活者PTX3水平及PTX3与死亡关联的结果均与样本量相关,但与男性比例无关;AUC与样本量和男性比例均相关。
证据类型、等级与局限
- 证据类型:系统评价与荟萃分析(纳入队列和病例对照研究)。
- 局限:原文未报告局限性
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The purpose of this study was to clarify the prognostic value of Pentraxin-3 (PTX3) on the mortality of patients with sepsis.
METHODS: Publications published up to January 2021 were retrieved from PubMed, EMBASE, and the Cochrane library. Data from eligible cohort and case-control studies were extracted for the meta-analysis. Multivariate regression analysis was used to evaluate the correlation of the outcomes with sample size and male proportion.
RESULTS: A total of 17 studies covering 3658 sepsis patients were included. PTX3 level was significantly higher in non-survivor compared to survivor patients (SMD (95% CI): -1.06 (-1.43, -0.69), P < 0.001). Increased PTX3 level was significantly associated with mortality (HR (95% CI): 2.09 (1.55, 2.81), P < 0.001). PTX3 showed good predictive capability for mortality (AUC:ES (95% CI): 0.73 (0.70, 0.77), P < 0.001). The outcome comparing PTX3 level in non-survivors vs. survivors and the outcome of the association between PTX3 and mortality were associated with sample size but not male proportion. AUC was associated with both sample size and male proportion.
CONCLUSIONS: PTX3 level was significantly higher in non-survivor compared to survivor patients with sepsis. Elevated PTX3 level was significantly associated with mortality. Furthermore, the level of PTX3 might predict patient mortality.
参考来源
- Wang G, Jiang C, Fang J, et al. Pentraxin-3 as a predictive marker of mortality in sepsis: an updated systematic review and meta-analysis. Crit Care. 2022. PMID: 35676730. doi:10.1186/s13054-022-04032-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。